Healthcare Professionals Patients
Professional asthma resources, EIB resources, and COPD resources

Professional asthma, EIB, and COPD resources

We understand that you want to give your patients the best care possible. As a service to you, we’ve provided links to several professional organizations that offer educational and networking opportunities for healthcare providers who treat asthma, EIB, and COPD.

ProAir® HFA (albuterol sulfate) Inhalation Aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Important Safety Information

  • Inhaled albuterol sulfate can produce paradoxical bronchospasm that may be life-threatening. It should be recognized that paradoxical bronchospasm, when associated with inhaled formulations, frequently occurs with the first use of a new canister.
  • Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma.
  • ProAir HFA, as with all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias, and hypertension), convulsive disorders, hyperthyroidism, and diabetes.
  • Potential drug interactions can occur with beta-blockers, diuretics, digoxin, or monoamine oxidase inhibitors, and tricyclic antidepressants.
  • Do not exceed the recommended dose.
  • Adverse events, which occurred at an incidence rate of at least 3% with ProAir HFA, include headache, tachycardia, pain, dizziness, pharyngitis, and rhinitis.
©2011 Teva Respiratory, LLC. This site is intended for U.S. residents only. All Rights Reserved.
ProAir® HFA is a registered trademark of Teva Respiratory, LLC.
EIB Active™ is a trademark of Teva Respiratory, LLC. EIB Active™ is sponsored by Teva Respiratory.

101449